ARCHIVES

House Subcommittee Recommends $137.7 Million Increase For NCI

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976